Alliance Pharma PLC's (LON:APH) Peter Butterfield tells Proactive London's Andrew Scott they're on track to hit full-year expectations after delivering a solid first-half performance.
Revenues for the period were £70.3mln, up 28% on a constant currency basis, or an organic 10% if the impact of recent purchases was stripped out.